Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene

Cardiovascular Research

Volumn 66, Issue 1, 2005, Pages 94-103

  Nishikimi, Toshio ^a,b   Hagaman, John R ^a   Takahashi, Nobuyuki ^a   Kim, Hyung Suk ^a   Matsuoka, Hiroaki ^b   Smithies, Oliver ^a   Maeda, Nobuyo ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Atrial natriuretic peptide; Heart failure; Natriuresis; Natriuretic peptide receptor A; Renin aldosterone system

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; GUANYLATE CYCLASE; MESSENGER RNA; MYOSIN HEAVY CHAIN; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE RECEPTOR A; NEUROHORMONE; RECEPTOR PROTEIN; RENIN; SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTOCAVAL FISTULA; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENE MUTATION; GENETIC SUSCEPTIBILITY; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE; HEART VOLUME; HEART WEIGHT; HEMODYNAMICS; HETEROZYGOSITY; HOMOZYGOSITY; HYPERTENSION; IN VIVO STUDY; KIDNEY MASS; LUNG WEIGHT; MOUSE; NONHUMAN; ORGAN WEIGHT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SODIUM URINE LEVEL; URINARY EXCRETION; WILD TYPE;

ALDOSTERONE; ANGIOTENSIN I; ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD VOLUME; CYCLIC GMP; DISEASE SUSCEPTIBILITY; GUANYLATE CYCLASE; HEART FAILURE, CONGESTIVE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MODELS, ANIMAL; MYOCARDIUM; MYOSIN HEAVY CHAINS; NATRIURETIC PEPTIDE, BRAIN; PROTEIN ISOFORMS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RENIN; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 14844362512     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.12.014     Document Type: Article

References (37)

1. R.W. Schrier, and W.T. Abraham Hormones and hemodynamics in heart failure N. Engl. J. Med. 341 1999 577 585
2. H. Ruskoaho Cardiac hormones as diagnostic tools in heart failure Endocr. Rev. 24 2003 341 356
3. Y. Saito, K. Nakao, K. Nishimura, A. Sugawara, K. Okumura, and K. Obata Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function Circulation 76 1987 115 124
4. N. Nagaya, T. Satoh, T. Nishikimi, M. Uematsu, S. Furuichi, and F. Sakamaki Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure Circulation 101 2000 498 503
5. J. McMurray, and M.A. Pfeffer New therapeutic options in congestive heart failure: Part I Circulation 105 2002 2223 2228
6. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, and A. Perez The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N. Engl. J. Med. 341 1999 709 717
7. G. Chu, K. Haghighi, and E.G. Kranias From mouse to man: understanding heart failure through genetically altered mouse models J. Card. Fail. 8 2002 S432 S449
8. K. Nakao, Y. Ogawa, S. Suga, and H. Imura Molecular biology and biochemistry of the natriuretic peptide system: I. Natriuretic peptides J. Hypertens. 10 1992 907 912
9. H.H. Chen, and J.C. Burnett Natriuretic peptides in the pathophysiology of congestive heart failure Curr. Cardiol. Rep. 2 2000 198 205
10. T. Nakayama, M. Soma, Y. Takahashi, D. Rehemudula, K. Kanmatsuse, and K. Furuya Functional deletion mutation of the 5′-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese Circ. Res. 86 2000 841 845
11. P.M. Oliver, J.E. Fox, R. Kim, H.A. Rockman, H.S. Kim, and R.L. Reddick Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A Proc. Natl. Acad. Sci. U. S. A. 94 1997 14730 14735
12. P.M. Oliver, S.W. John, K.E. Purdy, R. Kim, N. Maeda, and M.F. Goy Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner Proc. Natl. Acad. Sci. U. S. A. 95 1998 2547 2551
13. J.W. Knowles, G. Esposito, L. Mao, J.R. Hagaman, J.E. Fox, and O. Smithies Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice J. Clin. Invest. 107 2001 975 984
14. M.R. Alexander, J.W. Knowles, T. Nishikimi, and N. Maeda Increased atherosclerosis and smooth muscle cell hypertrophy in natriuretic peptide receptor A-/-apolipoprotein E-/- mice Arterioscler. Thromb. Vasc. Biol. 23 2003 1077 1082
15. M. Scheuermann-Freestone, N.S. Freestone, T. Langenickel, K. Hohnel, R. Dietz, and R. Willenbrock A new model of congestive heart failure in the mouse due to chronic volume overload Eur. J. Heart Fail. 3 2001 535 543
16. R. Garcia, and S. Diebold Simple, rapid, and effective method of producing aortocaval shunts in the rat Cardiovasc. Res. 24 1990 430 432
17. T. Nishikimi, T. Horio, T. Sasaki, F. Yoshihara, S. Takishita, and A. Miyata Cardiac production and secretion of adrenomedullin are increased in heart failure Hypertension 30 1997 1369 1375
18. J.H. Krege, J.B. Hodgin, J.R. Hagaman, and O. Smithies A noninvasive computerized tail-cuff system for measuring blood pressure in mice Hypertension 25 1995 1111 1115
19. N. Takahashi, D.R. Chernavvsky, R.A. Gomez, P. Igarashi, H.J. Gitelman, and O. Smithies Uncompensated polyuria in a mouse model of Bartter's syndrome Proc. Natl. Acad. Sci. U. S. A. 97 2000 5434 5439
20. J.H. Wu, J. Hagaman, S. Kim, R.L. Reddick, and N. Maeda Aortic constriction exacerbates atherosclerosis and induces cardiac dysfunction in mice lacking apolipoprotein E Arterioscler. Thromb. Vasc. Biol. 22 2002 469 475
21. H.S. Kim, J.H. Krege, K.D. Kluckman, J.R. Hagaman, J.B. Hodgin, and C.F. Best Genetic control of blood pressure and the angiotensinogen locus Proc. Natl. Acad. Sci. U. S.A. 92 1995 2735 2739
22. T. Nishikimi, Y. Mori, N. Kobayashi, K. Tadokoro, X. Wang, and K. Akimoto Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats Hypertension 39 2002 1077 1082
23. T. Horio, T. Nishikimi, F. Yoshihara, H. Matsuo, S. Takishita, and K. Kangawa Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes Hypertension 35 2000 19 24
24. G.J. Perry, T. Mori, C.C. Wei, X.Y. Xu, Y.F. Chen, and S. Oparil Genetic variation in angiotensin-converting enzyme does not prevent development of cardiac hypertrophy or upregulation of angiotensin II in response to aortocaval fistula Circulation 103 2001 1012 1016
25. H.S. Kim, G. Lee, S.W. John, N. Maeda, and O. Smithies Molecular phenotyping for analyzing subtle genetic effects in mice: application to an angiotensinogen gene titration Proc. Natl. Acad. Sci. U. S. A. 99 2002 4602 4607
26. R. Holtwick, M. van Eickels, B.V. Skryabin, H.A. Baba, A. Bubikat, and F. Begrow Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A J. Clin. Invest. 111 2003 1399 1407
27. M.J. Semigran, C.N. Aroney, H.C. Herrmann, G.W. Dec Jr., C.A. Boucher, and M.A. Fifer Effects of atrial natriuretic peptide on myocardial contractile and diastolic function in patients with heart failure J. Am. Coll. Cardiol. 20 1992 98 106
28. I. Kishimoto, S.K. Dubois, and D.L. Garbers The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: acute handling of sodium and water in response to volume expansion Proc. Natl. Acad. Sci. U. S. A. 93 1996 6215 6219
29. S.K. Dubois, I. Kishimoto, T.O. Lillis, and D.L. Garbers A genetic model defines the importance of the atrial natriuretic peptide receptor (guanylyl cyclase-A) in the regulation of kidney function Proc. Natl. Acad. Sci. U. S. A. 97 2000 4369 4373
30. T. Nishikimi, K. Miura, N. Minamino, K. Takeuchi, and T. Takeda Role of endogenous atrial natriuretic peptide on systemic and renal hemodynamics in heart failure rats Am. J. Physiol. 267 1994 H182 H186
31. A. Wada, T. Tsutamoto, Y. Matsuda, and M. Kinoshita Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors Circulation 89 1994 2232 2240
32. E. Hackenthal, M. Paul, D. Ganten, and R. Taugner Morphology, physiology, and molecular biology of renin secretion Physiol. Rev. 70 1990 1067 1116
33. H. Matsuoka, M. Ishii, T. Sugimoto, Y. Hirata, T. Sugimoto, and K. Kangawa Inhibition of aldosterone production by alpha-human atrial natriuretic polypeptide is associated with an increase in cGMP production Biochem. Biophys. Res. Commun. 127 1985 1052 1056
34. S.J. Shi, H.T. Nguyen, G.D. Sharma, L.G. Navar, and K.N. Pandey Genetic disruption of atrial natriuretic peptide receptor-A alters renin and angiotensin II levels Am. J. Physiol., Renal. Physiol. 281 2001 F665 F673
35. F. Pieruzzi, Z.A. Abassi, and H.R. Keiser Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure Circulation 92 1995 3105 3112
36. J.F. Arnal, M. Philippe, I. Laboulandine, and J.B. Michel Effect of perindopril in rat cardiac volume overload Am. Heart J. 126 1993 776 782
37. T. Mori, Y.F. Chen, J.A. Feng, T. Hayashi, S. Oparil, and G.J. Perry Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse Cardiovasc. Res. 61 2004 771 779